Sunday, September 6, 2026

Traditional VCs Reclaim 95% of AI Mega-Rounds as Tiger Global, SoftBank Retreat

Venture capital firms now lead large AI financing rounds after Tiger Global and SoftBank Vision Fund cut their deal count by over 95% since 2021. The 2025 cohort includes just 1,440 companies raising $50M+—half the previous cycle—as traditional VCs dominate the AI wave with higher valuations and extended exit timelines.

Traditional VCs Reclaim 95% of AI Mega-Rounds as Tiger Global, SoftBank Retreat
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Traditional venture capital firms have recaptured control of AI-era mega-rounds after crossover investors retreated dramatically from the market. Tiger Global Management and SoftBank Vision Fund slashed their large-round participation by more than 95% between 2021 and 2025, according to Crunchbase data.

The shift returned dealmaking power to established VC firms, which now lead the majority of rounds exceeding $50 million. Private equity investors, overindexed in private companies during the 2021 peak, have scaled back significantly as venture capital reclaimed dominance in AI-focused financing.

The 2025 financing landscape differs sharply from four years ago. Only 1,440 companies raised rounds of $50 million or more in 2025—roughly half the 2021 total. The contraction reflects both investor caution and a smaller pool of companies commanding mega-round valuations.

Traditional VCs are leveraging the AI boom to back companies at higher valuations than previous cycles. The rush into generative AI, machine learning infrastructure, and enterprise AI tools has created opportunities for firms willing to deploy large checks. Yet questions persist about returns, especially as exit timelines extend beyond historical norms.

Crunchbase noted the central uncertainty facing investors: "Will this new cohort of highly valued companies deliver outsized returns in the coming years?" The answer depends on whether AI startups can justify their valuations through revenue growth and eventual public market exits or acquisitions.

The Tiger Global and SoftBank pullback reflects broader market dynamics. Both firms deployed capital aggressively in 2020-2021, participating in hundreds of large rounds. Their retreat left a vacuum that traditional VCs quickly filled, reasserting their position in the market hierarchy.

Some portfolio strategies now include hedges against market shifts. Lara Banks noted that Makena's Stripe exposure serves as a hedge against Visa, since Stripe could potentially use crypto rails to disrupt Visa's payment network—illustrating how VCs are positioning for multiple technology disruption scenarios simultaneously.

The 2025 resurgence in large rounds signals a structural shift back to VC-led dealmaking. Whether this cohort generates returns comparable to previous technology waves remains the defining question as AI companies race to achieve scale and profitability.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: High
  1. [1]News articleYahoo Finance· January 19, 2026
    Andreessen Horowitz Makes a $3 Billion Bet Against the AI Bubble
  2. [2]News articleCrunchbase News
    Crunchbase Data: The AI Boom Has Drastically Changed Who’s Funding The Hottest Companies In 2025 Vs. 2021
  3. [3]Press releaseGlobeNewswire· December 22, 2025
    Eos Energy Honors Outgoing Chair Russ Stidolph for Years of Leadership and Investment and Appoints Industry Veteran Joseph Nigro as Chair of the Board of Directors
  4. [4]Press releaseGlobeNewswire· February 19, 2026
    NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
  5. [5]News articleYahoo Finance· November 18, 2025
    ‘Our funds are 20 years old’: limited partners confront VCs’ liquidity crisis
  6. [6]News articleYahoo Finance· February 20, 2026
    The OpenAI mafia: 18 startups founded by alumni
  7. [7]Earnings callNasdaq· February 25, 2026
    Erie Indemnity (ERIE) Q4 2025 Earnings Transcript
  8. [8]News articleYahoo Finance· February 25, 2026
    Oak-Eagle AcquireCo, Inc. Announces Pricing Terms for the Previously Announced Tender Offers and Consent Solicitations for Any and All of Electronic Arts Inc.'s 1.850% Senior Notes Due 2031 and 2.950% Senior Notes Due 2051
  9. [9]Press releaseGlobeNewswire· February 10, 2026
    OnSpark Launches AI-Powered Partnership Engine Built to Replace Guesswork With Verified Growth Opportunities
  10. [10]Press releaseGlobeNewswire· February 23, 2026
    Recyclable Polyethylene-Based Laminates Market Set Projected to Reach USD 5.92 Billion by 2035 with a 9.0% CAGR
  11. [11]News articleYahoo Finance· February 23, 2026
    Ripple CEO: 90% Chance Crypto Bill Passes By April, But What Do Prediction Markets Say?
  12. [12]Press releaseGlobeNewswire· February 25, 2026
    Vopak reports record financial results for 2025 and announces shareholder distributions program of around EUR 1.7 billion through year-end 2030
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com